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Abstract
Greater El Monte Community Hospital (GEMCH), the Los Angeles Department of Public
Health, and the Centers for Medicare and Medicaid Services assisted in the first documented
case of Ebola survivor delivery in the United States. A descriptive qualitative review of
GEMCH’s events and the limited documented cases of outcomes of baby deliveries among
EVD survivors is discussed. Limited resources and capacity in many developing countries
impact adversely on the outcomes of the EVD survivors and their neonates. Three lessons for
public health workers emerge: (1) the need for the United States to strengthen their capability
to manage EVD cases and other highly contagious and severe infectious diseases; (2) the
revealing that EVD survivors can deliver normal, EVD free babies when using the
recommendedguidelines; (3) The need for health careworkers to adopt and share the practical
procedures in the Recommended Guidelines by the CDC and LADPH from this event are
useful and can be shared with the medical fraternity. This case illustrates that EVD survivors
can be equally accepted and treated with success at designated health facilities. Demystifying
Ebola and eliminating social stigma surrounding the disease is crucial in this undertaking.
Keywords: Ebola virus disease (EVD), survivor, pregnancy, public health awareness,
neonate, stigma
1. Introduction
The West Africa Ebola virus disease (EVD) outbreak is globally recognized as one of the largest
and most severe Ebola epidemic. The disease affected over 28,000 people and the case mortality
rate was estimated to be around 50%. Among pregnant women, EVD increases the possibility for
spontaneous abortion and pregnancy-associated hemorrhage. In addition, neonatal mortality
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rate has been found to be high with almost no chances of survival [1]. Vertical transmission from
mother to the fetus is not well understood. It can occur during the acute EVD infection leading to
intrauterine fetal death or as stillbirth, or neonatal death. Acutely infected women have high
levels of Ebola viral nucleic acid persist in the amniotic fluid following the clearance of viremia; it
is not known if this fluid is infectious. Outside of this acute period of infection, little is known
about vertical transmission. Furthermore, research on pregnancy outcomes among mothers who
have recovered from EVD is limited. The media too has influenced community perception of risk
and enhanced stigma against EVD survivors. Public health awareness is needed to educate the
individual and community on health issues related to EVD. As of June 2016, an estimated 17,232
people survived the West Africa EVD outbreak [2]. Among the survivors 5000 women are of
childbearing age [3]. Some of these women will require obstetric care. The aim of this study is to
examine the outcomes at baby delivery among pregnant EVD survivors. There has been
contrasting results in developed countries versus developing countries. The care provided to
EVD patients and survivors requires evaluation in order to support the patient throughout their
illness and recovery. In women who have been infected while pregnant, the virus may be found
in the placenta, amniotic fluid and fetus.
2. Methods
To assess the outcomes of EVD survivors giving birth, a case study from the AHMC Health
System facility and desk research was conducted. The primary case includes the first
documented EVD survivor to give birth in the United States. The facility worked in collabora-
tion with the Centers for Disease Control and Prevention (CDC) and Los Angeles County
Department of Public Health (LACDPH) to provide coordinated care. This case study pro-
vided an empirical review which explores the outcomes of EVD survivors giving birth in a
real-time context. Desk review was chosen to supplement this primary research and involved
collecting data from existing resources. The systematic review collected and summarized
empirical evidence related to Ebola survivors giving birth. The database used for desk research
included PubMed and WorldCat. PRISMA was used to improve the quality of the results
through identification, screening, and eligibility criteria.
2.1. First documented EVD survivor giving birth in United States
A 29-year-old physician fromWest Africa contracted EVD in July 2014, after caring for an EVD
patient in Nigeria. On July 29, the woman began having generalized feelings of malaise, joint
and muscle pain. She self-administered antimalarial medications which were effective in
treating arthralgia and myalgia [4]. On August 1, the woman developed a fever, and on
August 3, she started vomiting and had diarrhea. The woman was admitted to an Ebola
treatment center. She was isolated after receiving positive results of a real-time reverse tran-
scription polymerase chain reaction (PCR).
According to the woman, she spent 13 days in an Ebola treatment center, where she was
treated with oral rehydration therapy (fluid with modest amounts of sugar and salts used to
correct dehydration), and acetaminophen (an antipyretic and pain reliever). In addition, a
Advances in Ebola Control44
second course of antimalarial medications was also administered [4]. She was discharged from
the Ebola treatment center on August 16, after testing negative for 2 separate EVD real-time
reverse transcription PCR results. After her recovery, she developed some weariness, lethargy,
loss of appetite, continued joint pain, and spot baldness. She did not report any sleep distur-
bances, headaches, or vision problems [4]. The woman’s symptoms resolved 2–3 months later,
and she fully recovered. Eight months prior to her EVD diagnosis, the woman had a sponta-
neous abortion at 10 weeks of gestation [4]. In January 2015, 22 weeks after her last negative
EVD real-time reverse transcription PCR, she became pregnant again. The woman received
routine prenatal care in West Africa. At her 25th week of pregnancy, a comprehensive ultra-
sound investigation was performed in Los Angeles County, California. The ultrasound assess-
ment revealed standard fetus development [4].
In November 2015, Greater El Monte Community Hospital (GEMCH) treated this woman.
GEMCH worked in cooperation with the Centers for Disease Control and Prevention (CDC) and
the Los Angeles County Department of Public Health (LACDPH) throughout the patient’s deliv-
ery process [5]. GEMCH identified staff members who were willing to assist during labor and
delivery for the patient, and at 40 weeks and 1 day of gestation, labor was induced. Two doses of
vaginal misoprostol, oxytocin, and an epidural anesthesia for pain management were adminis-
tered to the patient. The woman successfully gave birth to a nine pound baby by normal delivery.
The baby scored eight and nine on the Apgar scale at 1 minute and 5 minutes of age, respectively..
The mother had a second-degree perineal laceration, which was repaired. The mother and her
baby (Figures 1 and 2) were discharged from the hospital 36 hours postpartum [5]. The pair was
Figure 1. First documented mother EVD survivor in USA with new born baby and nurse, 2015.
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monitored for 6 weeks following the delivery, after which they returned home toWest Africa. This
case should raise awareness that EVD survivors can deliver healthy normal babies free of EVD.
Upon delivery, the Centers for Disease Control and Prevention (CDC) and Los Angeles County
Department of Public Health (LACDPH) examined the mother’s blood and the baby umbilical-
cord blood. Oral and vaginal swabs were also sampled. Additional specimens were obtained
from breast milk, first meconium, the placenta, and the amniotic fluid. All samples tested
negative for EVD [5]. One week prior to the delivery, EVD real-time reverse transcription
PCR testing was carried out on the patient’s blood by both the LACDPH’s laboratory and the
CDC’s Viral Special Pathogens Branch [5]. Both tests were reported negative for EVD. How-
ever, Ebola serum antibodies were detected.
2.2. Liberia EVD survivor
In 2014, a 26-year-old Liberian nurse assistant was recognized by Time Magazine. She was and
awarded Persons of the Year 2014 by Time Magazine in recognition of her efforts to fight EVD.
The woman had contracted EVD in the summer of 2014 and experienced the acute phase of
EVD alongside her sister and fiancé, now husband, at the time [6]. She was discharged with
Ebola free status from the Ebola Treatment Centre on August 28, 2014. Médecins Sans
Frontières hire her as mental health counselors in their Ebola units [7]. The woman became
pregnant with her fourth child in the summer of 2016, 2 years after her initial contraction of
EVD. She experienced a difficult pregnancy which included gestational hypertension. In Feb-
ruary 2017 she delivered by a cesarean section at Eternal Love Winning Africa Hospital
(ELWA). She was discharged a few hours later. Soon after arriving home, the woman collapsed
and began frothing at her mouth. Her spouse swiftly returned her to ELWA Hospital on the
evening of February 19, 2017. She developed convulsions and seizures before admission [7].
With some hesitation she was eventually admitted to the hospital. She died on February 21,
2017, just 4 days after giving birth. She is survived by her husband and four children [8]. It is
not known if her fourth child has been tested for the EVD antibodies.
Figure 2. GEMCH staff with first documented mother EVD survivor in USA with new born baby, 2015.
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2.3. Sierra Leone EVD survivor
A similar pregnancy was reported in Sierra Leone in ac EVD survivor. She contracted the EVD
infection when receiving gynecological services for her first pregnancy from a nurse, who had
some physical contact with an infected person in Guinea during a memorial service. The first
trimester of her gestation had complications which led into a miscarriage in May 2014. She was
subsequently diagnosed with EVD [3]. She was discharged from the hospital on June 8, 2014 as
Sierra Leone’s first EVD survivor. Months after her recovery, she got pregnant again. She gave
birth to a healthy baby boy on August 9, 2015. The baby was fed on formula milk substitutes.
Only weeks after the baby was born, he developed a fever and died of an infection apparently
not related to EVD. .
2.4. Other reported baby deliveries among Ebola survivors
Only one woman in the acute phase of EVD is reported to have given birth to a live, full term
baby. This mother developed fever 4 days prior to delivery and the baby also developed fever
and died 3 days later [9]. In the EVD outbreak at Mission Hospital in Yambuku, it was
reported that 11 live babies were delivered from mothers in the acute stage of their EVD
infection [9]. All babies had died in what appears to be neonatal mortality related to EVD. No
other pathological data was available. Seven out of 10 babies were reported to have developed
fevers. The route of infection from mother to baby is not clear. It is likely transmission occurred
during gestation, birth, or through breast milk.
Although the virus has been isolated in breast milk, the risk of transmission must be balanced
against the risk of malnutrition and other infections. If there is a safe alternative breastfeeding
is not advisable [9, 10]. Neonates breastfed by mothers in the acute phase of their EVD
infection have been reported to have become infected with EVD. Lactating women who are
sick with EVD should be placed into isolation until recovery. Safer feeding options such as safe
pasteurized donor milk or Ready to Use Infant Formula (RUIF), should be given to infant
when available [3]. Breastfeeding shortly before convalesce of EVD may still expose the
newborn to unnecessary risk. If available, laboratory testing of breast milk should be done to
evaluate the EVD content of the milk, and if found negative breastfeeding can commence.
Breastfeeding after full recovery from EVD is relatively safe and should be encouraged as there
are many benefits of breast milk.
3. Discussion
3.1. Addressing stigma
There is always social stigma surrounding individuals infected with EVD and regnant
Ebola survivors are certainly at risk [11]. In major outbreaks thinly veiled prejudice is
frequent [12]. The isolation of patients and the associated ostracism impacts the quality of
life for those affected and their communities. Furthermore, the poor level of awareness
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about transmission of the infection further undermined confidence and trust [11]. Mass
communication and social media influenced community perception during the 2014 EVD
epidemic [13]. The potential international hazard posed by EVD generated extensive
media attention [3]. Structural deficiencies such as poverty, lack of education, and political
conflicts further undermined the response and fueled stigma around EVD [14]. These
issues fused with cultural norms led to mistaken beliefs and behavior regarding EVD
and its mode of transmission [14]. Misguided understanding and stigma in individual
communities also led to harassment, rejection and persecution [11].
Health providers need to support patients and those affected to access care and management
free of stigma and discrimination. Emergency preparedness is needed to promote an enabling
environment to overcome misconceptions and overcome related fear. Healthcare workers need
to recognize the fear highly contagious diseases create, rather than treat those infected or are
recovering from the disease as pariahs, need to overcome that apprehension to create pre-
paredness. This case illustrates the need for health care providers to advocate for Assurance of
the basic rights of the patients irrespective of the medical condition is essential in managing
emerging infections like Ebola with high mortality. Ebola survivors should equally be accepted
and managed at health facilities.
3.2. Promoting public education
Health education is critical in reducing misconceptions and fear. Initially, no hospital was
willing to volunteer to admit this mother despite an appeal from the CDC and LACDPH.
This would be the first documented EVD survivor to deliver in the USA. However,
through partnership with CDC and LACDPH, the staff at GEMCH was educated about
transmission and infection control and personal protection prior to delivery. With proper
knowledge, public education and reassurance, it was possible to mobilize interdisciplinary
teams for patient management. The United States is strengthening their capacity to man-
age EVD cases and other highly contagious and severe infectious diseases. In February
2015, 55 hospitals were designated as Ebola treatment centers. In June 2015, the Depart-
ment of Health & Human Services (HHS) adopted CDC guidelines and identified and
funded nine health facilities as regional EVD treatment centers for specialized emergency
medical care. In California, for instance, Cedars-Sinai Medical Center serves as the
regional treatment center and will serve Arizona, Hawaii, Nevada, and the U.S. territories
in the Pacific.
3.3. Enhancing continuing medical training
A study published in the American Journal of Infection Control analyzed conventional train-
ing programs and reinforced training programs with their ability to decrease self-
contamination during the usage of basic PPE and enhanced PPE. The reinforced training pro-
grams provided evidence of improvement in adhering to protocol and proficiency. However,
there is still apprehension on a perfect barrier to infection contamination as this remains
elusive [15]. According to the findings from the Ebola cases introduced, it is crucial for
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healthcare providers to work in partnership in educating health workers and patients. The
treatment must be provided in a manner that promotes patient dignity and comfort at the
appropriate level of care. Healthcare facilities need to bring awareness to their physicians and
medical staff in regard to pregnant Ebola survivors who have fully recovered. These patients
pose virtually no risk to others including the neonates [16]. Thus healthcare workers can safely
treat EVD survivors.
Recommended Guidelines.
Below is a summary of the Recommended Guidelines provided by the CDC and LADPH
directly drawn from the GEMCH Ebola survivor delivery event:
a. Before delivery: For pregnant patients with intact membranes, medical staff is not required
to utilize Personal Protective Equipment (PPE). Routine hand hygiene before and after
contact with the patient are required.
b. For vaginal exams with rupture membrane: face protection with a face mask and face shield,
fluid-resistant gowns, and gloves are required to prevent mucous membranes and
splashes exposure.
c. For obstetrical and additional procedures where a large amount of fluid or blood is antici-
pated: such as artificial rupture of membranes and postpartum hemorrhage, PPE is
required.
d. During the delivery process: medical staff must wear PPE for the patient and staff’s safety.
Prevent exposure from mucous membranes, body fluids, and splashes, utilize face protec-
tion with a face mask and face shield, fluid-resistant gowns, double gloves, and boot
covers that extend to at least mid-calf, must be utilized. Pockets and surgical drapes
should be placed to prevent dousing of gowns and boots from body fluids during the
delivery process.
e. After the delivery: medical staff should not remove PPE until the mother’s gown and
bedding have been changed.
f. Post delivery: Upon vaginal and perineal examinations, non-sterile exam gloves and dis-
posable gowns must be utilized. Face protection is not needed unless the occurrence of
body fluid splash.
g. During initial contact with the baby: medical staff must apply PPE when giving them a bath.
If exposure to fluids when changing diaper and removing waste, non-sterile exam gloves
and two face masks must be worn. At all cost, skin-to-skin contact should be delayed until
baby is bathed.
There has been contrasting results in There is some contrast in outcomes of EVD survivors and
the neonate between developed and developing. The treatment offered to survivors who
become pregnant must be assessed and adapted to the different resource environments and
should be consistent to support the patient throughout the delivery process. Positive outcomes
can be achieved through the application of recommended guidelines so that EVD survivors as
well as the neonates may be assured of their future.
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4. Conclusion
The Ebola global threat has receded at least for now, but the world must remain vigilant. The
challenges created should also provide opportunities for building capacity for early detec-
tion and control. Health systems for surveillance and human resource development must be
reinforced as EVD and other highly infectious diseases may re-emerge in low resource
settings without adequate capacity for timely containment. A global response is required to
improve health care systems in all the affected regions [17]. The care provided to EVD
patients must be evaluated to support the patient throughout their illness. If the mortality
rate can be lowered through the application of the standard of care guidelines, EVD patients
and survivors will cooperate in l more seeking care. A number of medical problems have
been reported in survivors, including mental health. Ebola survivors need comprehensive
social support for the medical, mental and psychosocial challenges they face. In developing
countries resources are limited. For such instances early detection and action is vital to Ebola
containment. Further research is required to monitor the Ebola outbreaks as they occur in
order to gain true insight to developing delivery management needs of EVD survivors
especially during baby delivery.
Acknowledgements
The authors would like to thank all health facilities and staff involved with the research and
writing of this manuscript. We would personally like to thank Adaora Igonoh for allowing us
to share her story and bring to light EVD survivors can deliver normal, EVD free babies with
standard growth and development. The authors would like to thank the staff at GEMCH
including but not limited to Amanda Kamali, Moon Kim, Denise Jorison, Pierre Rollin, Okoi
Lilian, Julius Kpaduwa, Evelyn Calubaquib, Jose Ortega, Stella Kpadowa, Yang Cho, Ifeoma
Uisoha, and Sarah Schrier. Special appreciation to the Centers for Disease Control and Preven-
tion (CDC) and Los Angeles County Department of Public Health (LACDPH) for their help
and collaboration in this unique case. Furthermore, the authors would like to thank our
system’s A Team: Linda Marsh, Iris Lai, Patrick Petre, Philip Cohen, Karen Price-Gharzeddine,
Rick Castro. We would also like to thank the corporate project team members Su-Yen Wu,
Claire Huang, Molly Wu, Qian (Eowyn) Wen, Sasha Yu, Ping Lin.
Author details
Wen-Ta Chiu1,2, Jonathan Wu1, Stanley Toy1, Rachele Hwong1*, John J Stewart1 and
Jennifer Chang1
*Address all correspondence to: rachele.hwong@ahmchealth.com
1 AHMC Health System, Alhambra, United States
2 Taipei Medical University, Taipei, Taiwan
Advances in Ebola Control50
References
[1] Jamieson D. What obstetrician-gynecologist should know about Ebola: A perspective
from the Centers for Disease Control and Prevention. Obstetrics and Gynecology. 2014;
124(5):1005-1010. DOI: 10.1097/AOG.0000000000000533
[2] Situation Report. World Health Organization. 2016. Retrieved September 29, 2017, from
http://apps.who.int/iris/bitstream/10665/208883/1/ebolasitrep_10Jun2016_eng.pdf?ua=1
[3] Ebola (Ebola Virus Disease). 2016, June 10. Retrieved September 29, 2017, from https://
www.cdc.gov/vhf/ebola/outbreaks/2014-west-africa/survivors.html
[4] Kamali A, Jamieson DJ, Kpaduwa J, Schrier S, Kim M, Green NM, Mascola L. Pregnancy,
labor, and delivery after Ebola virus disease and implications for infection control in
obstetric services, United States. Emerging Infectious Diseases. 2016;22(7):1156-1161.
DOI: 10.3201/eid2207.160269
[5] Chiu WT, Toy S, Wu J. The first Ebola survivor to deliver a full term baby in the United
States. American Public Health Association. 2016;106(6):e4-e5
[6] McVeigh K. Ebola Survivor and Frontline Fighter Dies after Childbirth Complications.
2017, February 28. Retrieved September 29, 2017, from https://www.theguardian.
com/global-development/2017/feb/28/ebola-survivor-and-frontline-fighter-dies-after-childbirth-
complications
[7] Krausz J. Salome Karwah Dies: Liberian Ebola Fighter Loses Life After Childbirth. 2017,
February 27. Retrieved September 29, 2017, from http://www.newsmax.com/TheWire/salome-
karwah-dies-ebola-fighter/2017/02/27/id/775880/
[8] Why Ebola Fighters Are TIME's Person of the Year 2014. n.d. Retrieved September 29,
2017, from http://time.com/time-person-of-the-year-ebola-fighters-choice/
[9] Richens Y, Gerrard J. Ebola in pregnancy. British Journal of Midwifery. 2014;22(11):
771-775. DOI: 10.12968/bjom.2014.22.11.771
[10] Fischer WA, Hynes NA, Perl TM. Protecting health care workers from Ebola: Personal
protective equipment is critical but is not enough. Annals of Internal Medicine. 2014;161:
753-754. DOI: 10.7326/M14-1953
[11] Davtyan M, Brown B, Folayan MO. Addressing Ebola-related stigma: Lessons learned
from HIV/AIDS. Global Health Action. 2014. DOI: 10.3402/gha.v7.26058
[12] Sharfstein JM. On fear, distrust, and ebola. JAMA. 2015;313(8):784-784. DOI: 10.1001/
jama.2015.346
[13] Nagpal SJ, Karimianpour A, Mukhija D, Mohan D. Dissemination of 'misleading' infor-
mation on social media during the 2014 Ebola epidemic: An area of concern. Travel
Medicine and Infectious Disease. 2015;13(4):338-339. DOI: 10.1016/j.tmaid.2015.05.002
[14] Gates B. The next epidemic – lessons from Ebola. The New England Journal of Medicine.
2015;372(15):1381-1384. DOI: 10.1056/NEJMp1502918
Outcomes in Baby Deliveries among Pregnant Ebola Survivors
http://dx.doi.org/10.5772/intechopen.74669
51
[15] Casalino E, Astocondor E, Carlos J, Diaz-Santana DE, Aguila CD, Carrillo JP. Personal
protective equipment for the Ebola virus disease: A comparison of 2 training programs.
American Journal of Infection Control. 2015;43(12):1281-1287
[16] Ebola Virus Disease in Pregnancy: Screening and Management of Ebola Cases, Contacts
and Survivors. 2015. World Health Organization
[17] Baden LR, Kanapathipillai R, Campion EW, Morrissey S, Rubin EJ, Drazen JM. Ebola–an
ongoing crisis. The New England Journal of Medicine. 2014;371(15):1458-1459. DOI: 10.1056/
NEJMe1411378
Advances in Ebola Control52
